179 77

Cited 0 times in

Evidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020

DC Field Value Language
dc.contributor.author김지현-
dc.contributor.author이용찬-
dc.contributor.author임현철-
dc.date.accessioned2021-12-28T17:19:11Z-
dc.date.available2021-12-28T17:19:11Z-
dc.date.issued2021-07-
dc.identifier.issn1226-3303-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/187043-
dc.description.abstractHelicobacter pylori infection is one of the most common infectious diseases worldwide. H. pylori is responsible for substantial gastrointestinal morbidity with a high disease burden. Since the revision of the H. pylori Clinical Practice Guidelines in 2013 in Korea, the eradication rate of H. pylori has gradually decreased with the use of a clarithromycin based triple therapy. According to a nationwide randomized controlled study by the Korean College of Helicobacter and Upper Gastrointestinal Research released in 2018, the intention-to-treat eradication rate was only 63.9%, which was mostly due to increased antimicrobial resistance to clarithromycin. The clinical practice guidelines for treatment of H. pylori were updated based on evidence-based medicine from a meta-analysis conducted on a target group receiving the latest level of eradication therapy. The draft recommendations developed based on the meta-analysis were finalized after expert consensus on three recommendations regarding the indication for treatment and eight recommendations on the treatment itself. These guidelines were designed to provide clinical evidence for the treatment of H. pylori to patients, nurses, medical school students, policymakers, and clinicians. These may differ from current medical insurance standards, and will be revised if more evidence emerges in the future.-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherKorean Association of Internal Medicine-
dc.relation.isPartOfKOREAN JOURNAL OF INTERNAL MEDICINE-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAmoxicillin / therapeutic use-
dc.subject.MESHAnti-Bacterial Agents / therapeutic use-
dc.subject.MESHClarithromycin / therapeutic use-
dc.subject.MESHDrug Therapy, Combination-
dc.subject.MESHHelicobacter Infections* / diagnosis-
dc.subject.MESHHelicobacter Infections* / drug therapy-
dc.subject.MESHHelicobacter Infections* / epidemiology-
dc.subject.MESHHelicobacter pylori*-
dc.subject.MESHHumans-
dc.subject.MESHProton Pump Inhibitors / therapeutic use-
dc.subject.MESHRandomized Controlled Trials as Topic-
dc.subject.MESHRepublic of Korea / epidemiology-
dc.titleEvidence based guidelines for the treatment of Helicobacter pylori infection in Korea 2020-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorHye-Kyung Jung-
dc.contributor.googleauthorSeung Joo Kang-
dc.contributor.googleauthorYong Chan Lee-
dc.contributor.googleauthorHyo-Joon Yang-
dc.contributor.googleauthorSeon-Young Park-
dc.contributor.googleauthorCheol Min Shin-
dc.contributor.googleauthorSung Eun Kim-
dc.contributor.googleauthorHyun Chul Lim-
dc.contributor.googleauthorJie-Hyun Kim-
dc.contributor.googleauthorSu Youn Nam-
dc.contributor.googleauthorWoon Geon Shin-
dc.contributor.googleauthorJae Myung Park-
dc.contributor.googleauthorIl Ju Choi-
dc.contributor.googleauthorJae Gyu Kim-
dc.contributor.googleauthorMiyoung Choi-
dc.identifier.doi10.3904/kjim.2020.701-
dc.contributor.localIdA00996-
dc.contributor.localIdA02988-
dc.contributor.localIdA03418-
dc.relation.journalcodeJ02883-
dc.identifier.eissn2005-6648-
dc.identifier.pmid34092054-
dc.subject.keywordGuidelines-
dc.subject.keywordHelicobacter pylori-
dc.subject.keywordMeta-analysis-
dc.subject.keywordMicrobial sensitivity tests-
dc.subject.keywordTreatment-
dc.contributor.alternativeNameKim, Jie-Hyun-
dc.contributor.affiliatedAuthor김지현-
dc.contributor.affiliatedAuthor이용찬-
dc.contributor.affiliatedAuthor임현철-
dc.citation.volume36-
dc.citation.number4-
dc.citation.startPage807-
dc.citation.endPage838-
dc.identifier.bibliographicCitationKOREAN JOURNAL OF INTERNAL MEDICINE, Vol.36(4) : 807-838, 2021-07-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.